Security key
H17182108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 54,718,539
- Total 13F value
- $3,071,120,295
- Share change
- -1,477,537
- Put/Call ratio
- 90%
- SEC-reported price per share
- $56.14
- Number of holders
- 409
- Value change
- -$80,853,798
- Number of buys
- 149
- Number of sells
- 161
- Shares outstanding
- 97,024,000
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
409
Top holders
10
CRSP full security history
Ownership snapshot
Full 13F holder table
CRISPR Therapeutics AG SEC filings
CRISPR Therapeutics AG company facts
Broader feeds
Ownership snapshot
Top reported holders of CRSP - CRISPR Therapeutics AG - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F
Highest disclosed value: $361,396,203
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC has the largest disclosed position value at $361.4M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Disclosed position value
Top 5
ARK Investment Management LLC
$361.4M
Capital International Investors
$272.45M
Sumitomo Mitsui Trust Group, Inc.
$179.71M
Amova Asset Management Americas, ...
$178.75M
T. Rowe Price Investment Manageme...
$165.74M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
Company
|
—
denominator unverified
|
$361,396,203
7,990,188 shares
|
— | 31 Mar 2023 |
| Capital International Investors |
13F
Company
|
—
denominator unverified
|
$272,449,147
6,023,638 shares
|
— | 31 Mar 2023 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
Company
|
—
denominator unverified
|
$179,706,931
3,973,180 shares
|
— | 31 Mar 2023 |
| Amova Asset Management Americas, Inc. |
13F
Company
|
—
denominator unverified
|
$178,746,255
3,972,139 shares
|
— | 31 Mar 2023 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
—
denominator unverified
|
$165,740,000
3,664,371 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$126,579,818
2,798,581 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
409
Shares
54,718,539
Rows available
409
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
375
Q2 2023 holders
409
Holder diff
34
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|